Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Eur J Immunol. 2011 Jun 7;41(7):2064–2073. doi: 10.1002/eji.201040809

Table 1.

EAE in SLP-76cKO and SLP-76control mice

Incidence Onset (mean ± SEM) Maximal Score Mean Score**
* SLP-76control 10/12 15.5 ± 0.7 4 1.8 ± 0.3
SLP-76cKO 0/13 N/A 0 0

Combined data from a total of three individual experiments

*

The SLP-76control group includes CreT2− and non-transgenic mice in addition to SLP-76cHET

**

assessed at day 21 ± SEM; two-tailed student t-test was performed for comparison between SLP-76WT and SLP-76CKO mice assessed at day 21 (p < 0.0001)

Disease severity was scored on a scale of 0 – 5: 0, no illness; 1, limp tail; 2, hindlimb paresis; 3, partial hindlimb paralysis; 4, complete hindlimb paralysis; 5, moribund or dead.